TRT Provider Rating Methodology | TRT Provider Guide

Rating Principles at a Glance

Every published TRT Provider Guide rating should include:

A total score out of 100
A score for each of the six rating categories
The specific program and care model evaluated
The date the provider information was checked
The methodology version used
An evidence-confidence label
Material limitations and unresolved questions
A breakdown of the estimated total cost
The provider’s current affiliate relationship with TRT Provider Guide, if any
Links or citations identifying the principal sources used

Affiliate status, commission amount, advertising spend, brand popularity, and willingness to provide TRT Provider Guide with a backlink are never scoring factors.

See our current Affiliate Disclosure.

What Our Rating Measures

The TRT Provider Guide rating measures the documented features of a specific provider program at a specific point in time.

It evaluates whether the available evidence shows a clear and responsible process involving:

Clinical evaluation and diagnosis
Safety screening, fertility, and follow-up monitoring
Clinician, medication, pharmacy, and laboratory transparency
Total cost and commercial terms
Access, continuity, and patient control
Privacy, consumer protection, and marketing integrity

The rating gives substantial weight to the parts of a program that can affect patient safety and informed decision-making. A provider cannot make up for a weak diagnostic or monitoring process merely by offering a low price, fast shipping, attractive website, or responsive customer-service team.

What Our Rating Does Not Measure

Our rating does not establish:

Whether TRT is medically appropriate for a particular person
Whether an individual patient will qualify for a prescription
Whether a prescribed dose or formulation is appropriate
Whether a patient will experience symptom improvement
Whether one clinician is more skilled than another
The bedside manner of every clinician in a provider network
The purity, potency, or sterility of a specific medication shipment
The accuracy of every laboratory result
Compliance within every individual patient encounter
The experience every patient will receive
That a provider is endorsed, approved, certified, or accredited by TRT Provider Guide

We do not examine private medical records, observe clinician-patient visits, inspect clinics or pharmacies, test medication samples, reproduce laboratory testing, or independently audit a provider’s internal compliance systems.

A high score means the documented care model and consumer-facing information performed well under this methodology. It does not guarantee good care, a good outcome, or suitability for every patient.

Scope of Each Rating

A rating applies only to the program identified in the review.

A company may operate multiple programs, use different affiliated medical groups, work with different pharmacies, or follow different processes depending on the patient’s state, treatment, membership level, or insurance status. When those differences are material, we either:

Rate the programs separately;
Clearly identify which program the score covers; or
Withhold a single company-wide score because one number would be misleading.

Unless a review states otherwise, this methodology is designed for United States programs offering evaluation and ongoing treatment for adult men with possible testosterone deficiency or hypogonadism.

It should not automatically be applied to gender-affirming hormone care, testosterone therapy for women, fertility-only care, bodybuilding or performance-enhancement services, pediatric care, or treatment outside the United States. Those services may require different evidence standards, clinical guidelines, and rating criteria.

Online and local clinics are evaluated under the same core standards. A local office does not receive extra points merely because care is in person, and a telehealth provider does not lose points merely because care is remote. We evaluate what the care model requires, what it discloses, how it handles limitations, and whether its stated process supports responsible care.

Which Organizations Are Eligible for a Rating?

We may rate:

Direct-to-consumer telehealth TRT clinics
Local men’s health or hormone clinics
Urology, endocrinology, or primary-care programs with a defined TRT service
Multi-state medical platforms
Healthcare organizations coordinating evaluation, prescribing, medication fulfillment, and follow-up
Provider marketplaces when the marketplace’s role and the underlying clinical entities are clearly distinguished

We do not rate the following as complete TRT providers:

Testosterone-booster or dietary-supplement sellers
Laboratory-testing services that do not provide clinical care
Pharmacies that dispense prescriptions but do not evaluate and manage patients
Directories or lead-generation sites that only refer visitors elsewhere
Coaching, fitness, anti-aging, or wellness programs without an identifiable licensed clinical component
Websites purporting to sell prescription testosterone without a valid prescription
Programs whose actual clinical or commercial structure cannot be established

These businesses may be discussed or compared within an appropriately labeled article, but they should not receive a TRT provider score unless they satisfy the eligibility and evidence requirements below.

Minimum Evidence Required Before We Publish a Score

We do not assign a numerical score merely because a provider has a website or affiliate program.

Before publishing a rating, we must have enough evidence to identify and evaluate the following:

Clinical entity and care model: The organization or medical group responsible for evaluation and prescribing, and the role of any marketplace or administrative platform.
Clinician process: Who evaluates the patient, how the evaluation occurs, and whether prescribing is subject to an individualized clinician decision.
Diagnostic process: The provider’s stated approach to symptoms, medical history, testosterone testing, repeat testing, and additional evaluation when indicated.
Monitoring process: The stated plan for follow-up visits, laboratory monitoring, treatment response, side effects, and escalation.
Medication and pharmacy model: The types of medication offered, whether products are FDA-approved or compounded, and how dispensing pharmacies are selected or disclosed.
Pricing and terms: The principal initial and recurring charges, required commitments, automatic renewals, cancellation rules, and major exclusions from the advertised price.
Service area: The states or locations in which the program is offered and any material in-person or telemedicine requirements.

When this minimum evidence is unavailable, the provider receives:

Not Rated — Insufficient Verifiable Information

“Not Rated” is not a finding that the provider is unsafe. It means we do not have enough reliable information to produce a fair, reproducible score.

We identify the material information that was unavailable so readers and the provider can understand what prevented a rating.

Our 100-Point Rating Framework

The total rating contains six weighted categories.

Rating category	Maximum points
Clinical evaluation and diagnostic process	25
Safety, fertility, and ongoing monitoring	25
Clinician, medication, pharmacy, and laboratory transparency	15
Total cost and commercial terms	15
Access, continuity, and patient control	10
Privacy, consumer protection, and marketing integrity	10
Total	100

Clinical evaluation, safety, and monitoring account for half of the total score. This prevents a provider with attractive pricing or convenient service from receiving a leading rating when important clinical safeguards are poorly documented.

Category 1: Clinical Evaluation and Diagnostic Process — 25 Points

This category evaluates the process a provider says it uses to determine whether testosterone therapy should be considered.

We do not decide whether an individual provider must use one universal protocol. Clinical decisions should reflect the patient’s symptoms, medical history, laboratory findings, risk factors, goals, and the clinician’s judgment.

Criterion	Available points	What we examine
Clinician-led evaluation	5	Whether a licensed clinician evaluates the patient before prescribing and whether payment, testing, or completing a questionnaire is clearly distinguished from prescription approval.
Symptoms and medical history	5	Whether the process considers compatible symptoms or signs, medical history, medication use, prior treatment, sleep, weight, relevant illnesses, and other possible contributors rather than relying on a symptom quiz alone.
Testosterone testing and confirmation	5	Whether the provider describes appropriate testosterone measurement, timing, interpretation, and repeat early-morning testing when clinically appropriate instead of treating one isolated result as conclusive.
Evaluation of possible causes	5	Whether the process allows for additional testing, investigation of reversible or underlying causes, and referral when a pituitary, testicular, fertility, metabolic, medication-related, or other issue may require further evaluation.
Individualized eligibility and treatment selection	5	Whether prescribing remains an individualized clinical decision and treatment format, dose, goals, and alternatives are not predetermined by a sales package or guaranteed before evaluation.

We do not award extra points because a clinic promotes unusually high testosterone targets, more aggressive dosing, numerous add-on medications, “optimization,” or treatment for every patient above a certain age.

More treatment is not automatically better care.

Category 2: Safety, Fertility, and Ongoing Monitoring — 25 Points

This category evaluates whether the documented program includes safeguards before and after treatment begins.

Criterion	Available points	What we examine
Risk and contraindication screening	5	Whether the provider considers relevant medical conditions, medications, blood counts, cardiovascular history, blood pressure, sleep-apnea concerns, prostate or breast concerns, urinary symptoms, clotting history, and other individual risks when appropriate.
Fertility safeguards	5	Whether the provider asks about present and future fertility before treatment and clearly explains that external testosterone can suppress sperm production.
Baseline safety information	5	Whether the program obtains and reviews clinically appropriate baseline measurements, laboratory results, and risk information before treatment.
Follow-up and laboratory monitoring	5	Whether the provider describes a continuing plan to assess symptoms, testosterone response, blood counts, blood pressure, adverse effects, adherence, and other individualized markers.
Adjustment, escalation, and referral	5	Whether a licensed clinician reviews results and can adjust, pause, stop, or reconsider treatment; investigate a poor response; and refer the patient when the situation exceeds the program’s scope.

A provider does not receive full credit merely for saying that “labs are included.” We look for enough information to understand which stage of care the testing supports, how results reach the clinician, what follow-up occurs, and what happens when a result or symptom requires attention.

Category 3: Clinician, Medication, Pharmacy, and Laboratory Transparency — 15 Points

This category evaluates whether readers can determine who is responsible for care and where testing and medication fulfillment occur.

Criterion	Available points	What we examine
Clinical entity and clinician roles	3	Whether the responsible medical organization and the roles of physicians, nurse practitioners, physician assistants, nurses, coaches, and customer-service staff are accurately distinguished.
Licensure and geographic availability	3	Whether the provider accurately identifies where it operates, how patients are matched with appropriately licensed clinicians, and whether state or federal requirements may require additional steps or in-person care.
Medication transparency	3	Whether the provider identifies the medication or formulation being offered and clearly distinguishes FDA-approved products from compounded preparations, when applicable.
Pharmacy transparency	3	Whether the dispensing pharmacy or pharmacy network can be identified, the applicable state licensing information can be checked, and patients are told where their medication will come from before fulfillment.
Laboratory transparency	3	Whether the laboratory or testing partner can be identified, applicable CLIA information can be checked, and the provider explains material limitations of home collection or other testing methods.

An FDA-approved medication and a compounded preparation are not interchangeable regulatory categories. Compounded drugs can serve an important medical need, but they are not reviewed through the FDA’s premarket approval process. We therefore require providers to describe compounded products accurately rather than referring to them as FDA-approved, generic, or equivalent without adequate support.

We do not automatically disqualify a provider merely because it offers a compounded medication. We evaluate whether the product’s status, rationale, source, pharmacy, price, and limitations are made clear.

NABP accreditation or verification can be a useful pharmacy signal, but it is not treated as the only possible evidence of a legitimate pharmacy. We also consider applicable state pharmacy-board records and other official documentation.

Similarly, a CLIA certificate is a laboratory-verification signal. It does not, by itself, establish that every test is appropriate, every sample was collected correctly, or the provider’s complete clinical process is high quality.

Category 4: Total Cost and Commercial Terms — 15 Points

This category evaluates the complete financial commitment rather than the lowest number used in an advertisement.

Criterion	Available points	What we examine
Initial costs	3	Consultation, intake, testing, enrollment, setup, medical-review, or other charges required before treatment begins.
Recurring costs	3	Membership, medication, required visits, laboratory testing, supplies, shipping, refill, platform, or administrative fees.
First-year and renewal cost	3	Whether a reader can estimate a realistic first-year total and understand how the cost changes after an introductory offer, initial testing period, or annual renewal.
Commitment and cancellation	3	Minimum terms, automatic renewal, cancellation notice, pause rules, refund restrictions, shipped-medication policies, and what happens after cancellation.
Billing and coverage clarity	3	When payment occurs, whether a charge can occur before a patient approves treatment, what insurance or HSA/FSA statements actually mean, and whether the checkout flow matches the advertised offer.

How We Estimate Total Cost

When enough information is available, our estimated first-year cost includes:

Required consultation and enrollment fees
Required membership charges
Required baseline and follow-up laboratory testing
Medication
Administration supplies
Required shipping
Required follow-up visits
Other unavoidable program charges

We subtract discounts available to every qualifying customer.

We separate temporary introductory prices from continuing prices.

We do not subtract:

Affiliate-exclusive incentives that are not consistently available
Discounts requiring a long prepaid commitment unless that commitment is clearly stated
Insurance reimbursement that has not been established
HSA or FSA tax savings
Manufacturer assistance for which eligibility is uncertain
Referral credits
Optional add-ons that are not required for the reviewed program

When medication cost depends on formulation, dose, state, pharmacy, or clinical decision, we publish a range or scenario rather than presenting one artificially precise total.

Every material price statement should display the date checked. Providers set their own prices and may change them without notifying us.

Category 5: Access, Continuity, and Patient Control — 10 Points

This category evaluates how patients reach the clinical team and how the program handles ongoing care, interruptions, and transfers.

Criterion	Available points	What we examine
Access to a licensed clinician	2	Whether patients can identify how and when they communicate with a clinician rather than having all questions routed through sales or customer-service staff.
Continuity and clinical coverage	2	Whether the provider explains who reviews follow-up information, how clinician changes are handled, and what coverage exists when the usual clinician is unavailable.
Support channels and expectations	2	Available communication methods, stated hours, response expectations, and the distinction between clinical, billing, technical, and shipping support.
Refills, delays, and urgent concerns	2	How the provider handles refill timing, laboratory delays, medication-delivery problems, adverse effects, missed doses, and symptoms that require urgent or in-person evaluation.
Records, cancellation, and transfer of care	2	Whether patients can obtain laboratory results and medical records, leave the program, transfer care, and understand what happens to pending refills, prescriptions, and recurring charges.

Fast enrollment does not automatically earn a high access score. Speed can be convenient, but it is not a substitute for clinician availability, continuity, thoughtful evaluation, and a clear escalation process.

Category 6: Privacy, Consumer Protection, and Marketing Integrity — 10 Points

This category evaluates how the provider communicates with consumers and handles sensitive health and commercial information.

Criterion	Available points	What we examine
Medical and outcome claims	2	Whether claims are proportionate to available evidence and avoid unsupported promises involving guaranteed energy, muscle gain, sexual performance, weight loss, anti-aging, athletic performance, or universal benefit.
Prescribing claims, testimonials, and reviews	2	Whether the provider avoids guaranteeing a prescription, presents testimonials responsibly, discloses material relationships, and does not misrepresent consumer-review evidence as proof of medical effectiveness.
Privacy and health-data disclosures	2	Whether the privacy notice explains collection, use, retention, and sharing of health and personal information and avoids broad privacy promises that conflict with disclosed practices.
Ownership and role transparency	2	Whether readers can distinguish the consumer brand, administrative platform, medical group, laboratory, dispensing pharmacy, and any material sponsored or financial relationships.
Official actions and recurring consumer-protection concerns	2	Relevant final licensing, regulatory, disciplinary, privacy, billing, or consumer-protection findings, together with corroborated patterns that reveal a material difference between stated and actual policies.

We do not assume that every organization using telehealth is governed by the same privacy law in exactly the same way. Some entities and information may be subject to HIPAA, while other health technologies may fall under Federal Trade Commission rules or state privacy laws.

We therefore do not award full privacy credit merely because a website uses the phrase “HIPAA compliant.” We examine the provider’s actual public disclosures and clearly state the limits of what we can verify. This is not a cybersecurity audit or legal compliance opinion.

How Individual Criteria Are Scored

Each criterion receives 0%, 25%, 50%, 75%, or 100% of its available points.

100% of available points

The provider’s process is described specifically, supported by current and relevant evidence, and has no identified material contradiction.

75% of available points

The provider substantially satisfies the criterion, but a secondary detail, limitation, or verification item remains unclear.

50% of available points

The provider partially satisfies the criterion, but important information is general, incomplete, difficult to locate, or dependent on facts that cannot be fully confirmed.

25% of available points

Only limited support is available, key terms are ambiguous, or the disclosed process addresses only a small part of the criterion.

0% of available points

The criterion is not established, material evidence conflicts with the provider’s representation, or the documented process presents a concern directly relevant to the criterion.

A zero does not always mean that a provider definitely fails to perform the activity. It may mean the provider did not provide enough verifiable information to receive credit. We explain whether a low score reflects a documented practice, conflicting evidence, or missing information.

Not applicable criteria

A criterion is marked “not applicable” only when it genuinely does not apply to the reviewed care model. Missing or undisclosed information is not treated as “not applicable.”

When a criterion is genuinely inapplicable, the remaining criteria within that category are normalized to the category’s original weight:

Category score = points earned ÷ applicable points available × category weight

We disclose material exclusions when normalization could affect how the score is interpreted.

The final total is rounded to the nearest whole point. Category scores may be shown to one decimal place.

Critical Safeguard Rules

A high overall total cannot cancel out a critical gap in evaluation, monitoring, credentials, or medication fulfillment.

A provider cannot receive one of our highest rating bands or a “best,” “top,” or “recommended for comparison” designation unless it earns at least 70% of the available points in each of these categories:

Clinical evaluation and diagnostic process
Safety, fertility, and ongoing monitoring
Clinician, medication, pharmacy, and laboratory transparency

A rating may be withheld, suspended, or designated provisional when we identify an unresolved material concern such as:

The responsible clinical entity cannot be identified
The prescribing model or applicable clinician licensure cannot be reasonably established
The service appears to offer prescription testosterone without a valid prescription
Marketing guarantees a prescription before individualized clinician review
The documented program relies on a questionnaire without meaningful laboratory and clinician evaluation
No meaningful follow-up or monitoring process can be established
The medication or dispensing model remains unidentified after reasonable inquiry
An official restriction appears to prevent the provider from offering the service as advertised
Material provider documents contradict the price, cancellation, privacy, or clinical process represented to consumers
A current official action raises a directly relevant issue that cannot yet be fairly resolved

A pending complaint, lawsuit, investigation, or regulatory allegation is not treated as a final finding. We identify it as an allegation, use the issuing authority’s description, include the provider’s response when available, and avoid implying that a disputed matter has already been decided.

Rating Bands

Total score	Editorial interpretation
90–100	Very strong documented safeguards and transparency
80–89	Strong documented safeguards and transparency
70–79	Generally solid, with meaningful limitations or information gaps
60–69	Mixed; important gaps require closer comparison
Below 60	Substantial documented gaps, unresolved questions, or concerns
Not Rated	Insufficient verifiable information or ineligible care model

These descriptions apply to the documented program under this methodology. They are not clinical grades or predictions of patient outcomes.

A two-point difference should not be interpreted as proof that one provider offers meaningfully better medical care. Scores are structured comparison tools, not laboratory measurements.

Evidence Confidence Is Separate From the Score

Every rating should display one of the following evidence-confidence labels:

High confidence

The principal clinical-process, licensing, medication, pharmacy, laboratory, pricing, and policy facts are supported by detailed provider documents and, where applicable, independent official records. No major conflict remains unresolved.

Moderate confidence

The minimum evidence standard is satisfied and the principal program details are documented, but some information depends on provider statements, varies by state or patient, or could not be independently corroborated.

Limited confidence

The minimum publication standard is narrowly satisfied, but several material details remain incomplete, difficult to verify, or subject to meaningful variation. A limited-confidence score cannot receive a leading designation.

Insufficient evidence

The publication gate is not satisfied. No numerical rating is assigned.

Evidence confidence does not indicate whether a provider is good or bad. It indicates how much confidence readers can place in the factual record supporting our score.

Our Source Hierarchy

We prefer the most direct and authoritative source appropriate to each claim.

1. Government and regulatory sources

These may include:

U.S. Food and Drug Administration labeling, safety communications, databases, warning letters, and compounding materials
Drug Enforcement Administration controlled-substance and telemedicine materials
Department of Health and Human Services privacy and telehealth guidance
Centers for Medicare & Medicaid Services CLIA records
Federal Trade Commission advertising, endorsement, review, billing, and health-privacy materials
State medical, pharmacy, nursing, insurance, and consumer-protection records
Court records and final administrative orders when directly relevant

2. Clinical guidelines and peer-reviewed evidence

We use applicable professional guidelines and major peer-reviewed research to establish the medical benchmark against which provider claims and publicly described processes are evaluated.

A guideline does not allow us to decide how an individual patient should be treated, and reasonable professional judgment may differ. We use guidelines to identify the questions, safeguards, uncertainties, and disclosures that a responsible comparison should examine.

3. Official licensing, accreditation, and certification records

These may include state professional-license records, state pharmacy records, NABP resources, CLIA information, and other directly relevant official databases.

A credential or certification is described only for the scope it actually covers. We do not turn a limited credential into a broad claim that the entire company or program has been certified.

4. Provider-controlled documents

These may include:

Official pricing pages
Terms of service
Privacy notices
Consent forms
Frequently asked questions
Patient instructions
Cancellation and refund policies
Checkout disclosures
Pharmacy and laboratory information
Clinical-process descriptions
State-availability pages
Documents supplied directly by the provider

Official provider materials are often the best source for the provider’s own program terms. They are evidence of what the provider represents, not independent proof that every patient encounter follows the stated process.

5. Direct provider responses

We may ask a provider to clarify a material question or supply documentation. Provider responses are labeled as provider-supplied information unless independently corroborated.

A provider does not receive points merely for responding. Credit depends on the substance and reliability of the information supplied.

6. Consumer reports and third-party reviews

Consumer reports may help identify operational patterns involving:

Unexpected billing
Cancellation
Appointment access
Shipping
Refills
Communication
Record access
Customer support

They are not treated as proof that a treatment is medically effective or that a provider’s clinical process is safe.

How We Use Consumer Reviews

Third-party star averages do not directly add points to or subtract points from the TRT Provider Guide score.

Review platforms can contain genuine experiences, incentivized testimonials, selection bias, duplicate posts, manipulated reviews, outdated complaints, or reports that cannot be verified. A large number of positive reviews also does not establish medical effectiveness or guideline-concordant care.

Our rules are:

No single anonymous review changes a provider’s score.
A testimonial is not medical evidence.
Provider-selected success stories are not assumed to represent typical results.
A platform’s star average is not copied into our editorial score.
Repeated operational concerns are investigated rather than automatically accepted.
Where possible, we compare reported concerns with published policies, checkout terms, official records, or direct provider responses.
Material relationships, incentives, or free products connected with testimonials should be disclosed.
We distinguish current patterns from issues tied to an older program that has materially changed.

Consumer-review information may be included as a clearly labeled experience signal, but the core score remains based on the structured methodology on this page.

Verification Labels Are Not Quality Awards

Provider pages may display factual verification labels such as:

Data Verified
Pricing Verified
Membership Terms Verified
Laboratory Process Verified
Cancellation Terms Verified
State Availability Verified
Pharmacy Information Verified
Treatment Formats Verified

A verification label means only that the identified data field was matched to a cited source on the displayed verification date.

It does not mean that TRT Provider Guide:

Recommends the provider
Audited the provider’s clinical care
Certified the provider’s safety
Endorses a medication
Guarantees the information will never change
Verified every state, clinician, patient encounter, prescription, or medication shipment

Verification labels cannot be purchased. We do not require providers to pay, enroll in an affiliate program, provide a backlink, or advertise with us before correcting or verifying factual information.

How We Research and Calculate a Rating

Our standard rating workflow is:

Step 1: Define the exact program

We identify the program, service area, care model, treatment scope, and date being evaluated. We avoid combining materially different programs into one score.

Step 2: Collect the evidence

We review applicable medical and regulatory sources, provider-controlled pages and policies, official licensing or certification records, checkout disclosures, and other sources relevant to the six rating categories.

Step 3: Record each material fact

For material provider facts, we record:

What the source states
The source location
The date checked
Whether the fact is independently verified, provider documented, provider supplied, conflicting, or unresolved

Step 4: Reconcile inconsistencies

When an advertisement, pricing page, terms page, checkout screen, or provider response conflicts with another source, we investigate the difference rather than selecting the most favorable version.

We may contact the provider when clarification could materially change the score.

Step 5: Apply the rubric

Each criterion is scored using the point allocation and scoring anchors published on this page. Affiliate status and potential compensation are excluded from the calculation.

Step 6: Apply the evidence and safeguard rules

We determine whether the minimum evidence gate has been satisfied and whether any critical issue requires the score to be limited, suspended, designated provisional, or withheld.

Step 7: Conduct final editorial verification

A score is not published solely from automated extraction or an unexplained mathematical output. The category totals, material claims, sources, limitations, and commercial disclosures must be checked before publication.

This is an editorial verification step. It is not represented as medical review unless a named, qualified clinician has reviewed the specific page and version under our Medical Review Policy.

Step 8: Publish the complete rating record

The provider review should display the total score, category breakdown, evidence confidence, date checked, methodology version, important limitations, source links, affiliate status, and the practical reasons the provider may or may not fit a particular reader.

How Ratings Are Used in Rankings and “Best” Lists

The highest numerical score does not automatically appear first on every comparison page.

A ranking also depends on the question the page is answering. For example, a provider with a strong overall rating may not be the most relevant option for a reader who needs:

Insurance-based care
An in-person examination
Fertility-focused evaluation
Specialist management
A specific FDA-approved formulation
A needle-free option
Service in a particular state
Easier transfer from an existing clinician
A lower total first-year cost
More frequent clinician access

Any “best for” designation must identify:

Who the designation is for;
Which measurable factors support it;
The principal tradeoff or limitation;
The date the underlying facts were checked; and
Whether the provider has an affiliate relationship with TRT Provider Guide.

A provider ordinarily must score at least 75 out of 100, satisfy the critical-category thresholds, and have no unresolved critical concern before receiving an affirmative editorial designation.

Providers separated by two points or fewer are treated as a practical scoring tie unless a clearly disclosed fit factor supports a different order.

Affiliate and Commercial Independence

TRT Provider Guide may establish commercial relationships with some of the providers discussed on this site. Our Affiliate Disclosure explains the site’s current commercial status and relationships.

The following rules apply to every rating:

Affiliate status is not a scoring criterion.
Commission amount is not entered into the scoring formula.
A provider cannot purchase a higher score.
A provider cannot purchase a verification label.
A provider cannot pay to remove a material limitation.
A provider cannot require favorable language as a condition of an affiliate relationship.
A provider cannot prevent publication of a supported correction.
A non-affiliate provider may outrank an affiliate provider.
Ending a commercial relationship does not lower a provider’s score.
Beginning a commercial relationship does not raise a provider’s score.
Sponsored advertising, if accepted, must be visually separated from editorial ratings and rankings.
Provider-supplied information is evaluated under the same evidence rules regardless of commercial status.

Research priority may reflect reader demand, search interest, availability of verifiable information, and editorial capacity. We do not claim to review every TRT provider in the market. Inclusion and score are separate decisions.

Provider Participation and Right to Respond

Providers may submit documentation, corrections, updated pricing, state-availability information, pharmacy details, laboratory information, or other relevant evidence without charge.

Submitting information does not guarantee:

Inclusion
A numerical rating
A particular score
A favorable conclusion
Removal of supported criticism
Advance approval of our article
A backlink
An affiliate relationship

When a disputed fact could materially harm a provider or materially change the score, we seek direct evidence and, where practicable, give the provider an opportunity to clarify the record.

We identify provider statements as provider supplied when they cannot be independently corroborated. A lack of response is reported as a lack of response—not as an admission.

Submit a provider update or correction.

Corrections and Rating Updates

Provider prices, clinical models, medical groups, pharmacies, laboratory partners, service areas, terms, and regulatory requirements can change.

Each rating displays a verification date. A material update may trigger a partial or complete rescoring when we learn of a change involving:

Evaluation requirements
Laboratory testing
Fertility counseling
Monitoring
Clinician access
Medication formulations
FDA-approved or compounded status
Pharmacy relationships
State availability
Pricing
Automatic renewal
Cancellation or refunds
Privacy practices
Ownership or medical-group structure
A directly relevant official action

An active rating must receive a full revalidation at least once every 12 months. A rating that has not been revalidated within that period should be labeled Update Pending and removed from active “best” or recommended rankings until refreshed.

Price information may change sooner than the underlying rating. Every price-led comparison should therefore show a separate price-check date.

We cannot guarantee that every change will be detected immediately. Readers should verify current terms with the provider before paying or making a consequential healthcare decision.

Material corrections are dated and described rather than silently concealed. A change in score should identify whether it resulted from:

New provider information
A factual correction
A change in the provider’s program
A change in an official standard
A change in this methodology

Read our Corrections Policy.

Methodology Changes and Version Control

This methodology is versioned so readers can understand how a score was produced.

A material methodology change may include:

Changing category weights
Adding or removing a scored criterion
Changing a critical safeguard
Changing rating-band thresholds
Changing the minimum evidence standard
Changing how rankings use the total score

When a material change occurs, we:

Publish a new methodology version and effective date;
Explain the material change;
Avoid presenting old and new scores as directly comparable without context; and
Rescore active recommended providers under the new version before treating the new rankings as final.

Minor wording changes that do not alter how points are awarded may be recorded without creating a new major version.

Methodology Change Log

Version 1.0 — September 1, 2026

Established the 100-point TRT provider rating framework
Established six weighted rating categories
Established the minimum evidence gate
Established critical safeguard thresholds
Established separate evidence-confidence labels
Established rules for affiliate independence, verification labels, corrections, and annual revalidation

Who Produces TRT Provider Guide Ratings?

Provider ratings are published under the organizational byline:

TRT Provider Guide Editorial Team

This organizational byline identifies TRT Provider Guide as the publisher responsible for the research, scoring, sourcing, presentation, updates, and corrections. It does not claim that an unnamed physician, medical professional, patient, or fabricated individual wrote or reviewed the page.

We do not invent:

Author identities
Reviewer identities
Medical credentials
Personal treatment experiences
Provider-testing experiences
Facility inspections
Medication tests
Patient outcomes
Dates or verification work that did not occur

A page receives a “medically reviewed” label only when a named, qualified reviewer has reviewed that specific page and version, the reviewer’s credentials and relevant scope can be identified, and the review date is displayed.

Until those requirements are satisfied, readers should treat our ratings as evidence-cited editorial comparisons rather than medical review.

Read our Editorial Standards and Medical Review Policy.

Important Limitations

Even a detailed methodology has limits.

Provider information may be incomplete, state specific, temporarily inaccurate, or changed after our review. A provider’s published process may not describe every patient encounter. Licensing records may update after a delay. Pharmacy and laboratory relationships may differ by state. Pricing may depend on the prescribed formulation, dose, clinical decision, insurance coverage, or required monitoring.

We do not have access to every internal policy, contract, quality-control system, clinician communication, adverse event, complaint, refund, prescription, or patient record.

Our rating should be used as one comparison aid—not as the sole basis for selecting a clinician or beginning, changing, or stopping treatment.

TRT Provider Guide is an independent educational and comparison publisher. It is not a medical practice, telehealth provider, pharmacy, laboratory, manufacturer, insurer, licensing board, accrediting body, or government agency.

Frequently Asked Questions

Is the highest-rated TRT provider automatically the best provider for me?

No. The rating compares a documented program, not your medical history or personal needs. A lower-scoring provider may offer a specialist, local examination, insurance arrangement, treatment format, or state availability that makes it a more appropriate care route for a particular person.

Does a high rating mean TRT is appropriate for me?

No. A provider rating cannot establish a diagnosis or determine whether treatment is appropriate. That requires an individualized evaluation by a qualified licensed clinician.

Does a low rating mean a provider is unsafe?

Not necessarily. A low rating may reflect a documented concern, incomplete information, weak transparency, or several smaller limitations. The provider review should explain the reason for every material deduction.

Why can missing information reduce a score?

Transparency affects a patient’s ability to understand the care, cost, medication source, commitment, and available safeguards before paying. We do not assume that an undisclosed process is poor, but we also do not award points for a safeguard that cannot be established.

Can providers pay for a higher rating?

No. Providers cannot purchase points, verification labels, favorable conclusions, or removal of supported limitations.

Do affiliate providers receive extra points?

No. Affiliate status and commission amount are excluded from the scoring formula. The presence of an affiliate relationship is disclosed to readers.

Are patient star ratings included in the score?

No. Consumer reports may help identify patterns worth investigating, but third-party star averages do not directly determine the TRT Provider Guide score and are not treated as proof of medical effectiveness.

Are online providers scored differently from local clinics?

The same core standards apply. Differences inherent to the care model are described and evaluated without automatically favoring telehealth or in-person care.

Does offering more medications improve a provider’s score?

No. A larger treatment menu does not by itself establish better care. We look at whether available options are accurately described, selected through individualized clinical judgment, obtained from an identifiable source, and supported by appropriate follow-up.

Does offering compounded testosterone automatically lower a provider’s score?

Not automatically. Compounded products and FDA-approved products have different regulatory status. We evaluate whether the provider accurately discloses the product’s status, pharmacy, rationale, cost, limitations, and monitoring. Misrepresenting a compounded product as FDA-approved or as an approved generic would reduce the score.

Can a provider challenge or correct a rating?

Yes. Providers and readers may submit relevant documentation without charge. We evaluate the evidence under the same standards used in the original review. Providers do not receive a right to control the editorial conclusion.

How often are ratings updated?

A material provider change can trigger an earlier update. Active ratings must be fully revalidated at least once every 12 months, and price statements carry their own check dates.

Has a clinician medically reviewed this methodology?

Not at this time. This page does not carry a medically reviewed label. Any future medical review will identify the named reviewer, relevant credentials, page version, and review date.

Sources and Standards Used to Develop This Methodology

The sources below establish medical, regulatory, laboratory, pharmacy, privacy, advertising, and consumer-protection benchmarks. They do not endorse TRT Provider Guide or any rating we publish.

Sources last reviewed for this methodology: September 1, 2026.

Official guidance, product labeling, laws, provider programs, and regulatory requirements can change. We review the current source rather than relying only on the date or summary shown here.

Related TRT Provider Guide Policies

Medical and Editorial Disclaimer

TRT Provider Guide publishes educational and comparison information for adults in the United States. Our ratings are editorial assessments of documented provider programs. They are not medical advice, diagnosis, treatment, a clinical referral, a prescription recommendation, or a substitute for an individualized evaluation by a licensed healthcare professional.

Testosterone is a prescription controlled substance. Eligibility, prescribing requirements, state availability, medication availability, and telemedicine rules can change. Completing a questionnaire, purchasing a test, paying a fee, or consulting a provider does not guarantee a prescription.

Do not start, stop, change, share, or obtain testosterone or another prescription medication based on a provider rating. Discuss treatment decisions, fertility, laboratory results, side effects, and individual risks with a qualified licensed clinician who can review your complete medical history.

For a medical emergency, call 911 or seek immediate care.